INTRODUCTION: Human laboratory paradigms for examining stress- or cue-reactivity in substance-dependent individuals often involve exposure to pharmacological, psychosocial or physical laboratory procedures or drug paraphernalia. This study examines whether participation in such studies alters drug-seeking behavior and which patient attributes contribute to increased use. METHODS: In two separate studies, the relationship between participation and drug use post-study were examined. Cocaine-dependent participants received 1 microg/kg of corticotropin releasing hormone intravenously, underwent the Trier Social Stress Task, and were exposed to drug cues and various measures obtained. Cocaine use for 90 days prior and 28 days following the study was assessed. Methamphetamine-dependent participants were exposed to drug cues and various measures obtained. Methamphetamine use for 90 days prior and 14 days following the study was assessed. Weekly drug use was modeled using a 2-state hidden Markov model assuming two possible underlying states at each week. Bayesian estimation was used. Results are presented as posterior mean odds ratios (OR) and 95% credible intervals (CI). RESULTS: Participation decreased the odds of remaining in or transitioning to the high use state (cocaine study OR=0.04 [CI=0.01, 0.11]; methamphetamine study OR=0.39 [CI=0.07, 1.70]). In the cocaine study, older age increased the odds of remaining in or transitioning into the high use state (1.66 [CI=0.99, 2.96]). In the methamphetamine study, male gender increased the odds (2.70 [CI=1.10, 6.17]). CONCLUSION: Stress and cue exposure paradigms were associated with a decreased odds of drug use following participation.
INTRODUCTION:Human laboratory paradigms for examining stress- or cue-reactivity in substance-dependent individuals often involve exposure to pharmacological, psychosocial or physical laboratory procedures or drug paraphernalia. This study examines whether participation in such studies alters drug-seeking behavior and which patient attributes contribute to increased use. METHODS: In two separate studies, the relationship between participation and drug use post-study were examined. Cocaine-dependent participants received 1 microg/kg of corticotropin releasing hormone intravenously, underwent the Trier Social Stress Task, and were exposed to drug cues and various measures obtained. Cocaine use for 90 days prior and 28 days following the study was assessed. Methamphetamine-dependent participants were exposed to drug cues and various measures obtained. Methamphetamine use for 90 days prior and 14 days following the study was assessed. Weekly drug use was modeled using a 2-state hidden Markov model assuming two possible underlying states at each week. Bayesian estimation was used. Results are presented as posterior mean odds ratios (OR) and 95% credible intervals (CI). RESULTS: Participation decreased the odds of remaining in or transitioning to the high use state (cocaine study OR=0.04 [CI=0.01, 0.11]; methamphetamine study OR=0.39 [CI=0.07, 1.70]). In the cocaine study, older age increased the odds of remaining in or transitioning into the high use state (1.66 [CI=0.99, 2.96]). In the methamphetamine study, male gender increased the odds (2.70 [CI=1.10, 6.17]). CONCLUSION: Stress and cue exposure paradigms were associated with a decreased odds of drug use following participation.
Authors: David S Festinger; Douglas B Marlowe; Jason R Croft; Karen L Dugosh; Nicole K Mastro; Patricia A Lee; David S Dematteo; Nicholas S Patapis Journal: Drug Alcohol Depend Date: 2005-01-23 Impact factor: 4.492
Authors: Scott F Coffey; Michael E Saladin; David J Drobes; Kathleen T Brady; Bonnie S Dansky; Dean G Kilpatrick Journal: Drug Alcohol Depend Date: 2002-01-01 Impact factor: 4.492
Authors: Sudie E Back; Angela E Waldrop; Michael E Saladin; Sharon D Yeatts; Annie Simpson; Aimee L McRae; Himanshu P Upadhyaya; Regana Contini Sisson; Eve G Spratt; Julia Allen; Mary Jeanne Kreek; Kathleen T Brady Journal: Psychoneuroendocrinology Date: 2008-03-05 Impact factor: 4.905
Authors: James J Prisciandaro; Stacia M DeSantis; Cody Chiuzan; Delisa G Brown; Kathleen T Brady; Bryan K Tolliver Journal: Alcohol Clin Exp Res Date: 2011-09-20 Impact factor: 3.455
Authors: Dipankar Bandyopadhyay; Stacia M DeSantis; Jeffrey E Korte; Kathleen T Brady Journal: Am J Drug Alcohol Abuse Date: 2011-09 Impact factor: 3.829
Authors: Rachel L Tomko; Erin A McClure; Patrick A Cato; Julie B Wang; Matthew J Carpenter; Joshua L Karelitz; Brett Froeliger; Michael E Saladin; Kevin M Gray Journal: Addict Behav Date: 2019-07-15 Impact factor: 3.913
Authors: Sudie E Back; Karen Hartwell; Stacia M DeSantis; Michael Saladin; Aimee L McRae-Clark; Kimber L Price; Megan M Moran-Santa Maria; Nathaniel L Baker; Eve Spratt; Mary Jeanne Kreek; Kathleen T Brady Journal: Drug Alcohol Depend Date: 2009-09-02 Impact factor: 4.492
Authors: Leigh V Panlilio; Samuel W Stull; Jeremiah W Bertz; Albert J Burgess-Hull; William J Kowalczyk; Karran A Phillips; David H Epstein; Kenzie L Preston Journal: Psychopharmacology (Berl) Date: 2020-09-29 Impact factor: 4.530
Authors: Tanya C Saraiya; Amber M Jarnecke; Jennifer Jones; Delisa G Brown; Kathleen T Brady; Sudie E Back Journal: Drug Alcohol Depend Date: 2021-05-21 Impact factor: 4.852
Authors: Lee Seng Esmond Seow; Wei Jie Ong; Aditi Hombali; P V AshaRani; Mythily Subramaniam Journal: Int J Environ Res Public Health Date: 2020-09-07 Impact factor: 3.390